Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial

• Päätekijät: Yongliang Feng (Tekijä), Jing Chen (Tekijä), Tian Yao (Tekijä), Yue Chang (Tekijä), Xiaoqing Li (Tekijä), Rongqin Xing (Tekijä), Hong Li (Tekijä), Ruixue Xie (Tekijä), Xiaohong Zhang (Tekijä), Zhiyun Wei (Tekijä), Shengcai Mu (Tekijä), Ling Liu (Tekijä), Lizhong Feng (Tekijä), Suping Wang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2021-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (COVID-19) have a substantial burden on health-care systems around the world. This is a randomized parallel controlled trial for assessment of the immunogenicity and...